首页> 美国卫生研究院文献>BMC Medical Research Methodology >Analysis of Bayesian posterior significance and effect size indices for the two-sample t-test to support reproducible medical research
【2h】

Analysis of Bayesian posterior significance and effect size indices for the two-sample t-test to support reproducible medical research

机译:用于支持可重复医学研究的两次样本t检验的贝叶斯后验显着性和效应量指数分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In randomised clinical trials (RCT), the two-sample Student’s and Welch’s -test is one of the most popular statistical procedures conducted. The goal often can be defined to test the efficacy of a new treatment or medication and investigate the size of an effect. Common settings use a treatment and control group, and the goal is to measure differences in a response variable like blood pressure. The gold standard in medical research for deciding if a new treatment or drug was more effective than the control treatment or drug is the -value. The -value states if the researcher can deem the observed difference significant, that means unlikely to have occurred under the assumption of the null hypothesis. The dominance of -values when comparing two groups in medical (and other) research is overwhelming: Nuijten et al. [ ] showed in a meta-analysis that of 258105 -values reported in journals between 1985 and 2013, 26% belonged to a -statistic, see also Wetzels et al. [ ].
机译:在随机临床试验(RCT)中,两个样本的Student和Welch检验是最受欢迎的统计程序之一。通常可以定义目标,以测试新疗法或药物的功效并研究效果的大小。常见设置使用治疗和对照组,目标是测量血压等反应变量的差异。决定新疗法或药物是否比对照疗法或药物更有效的医学研究的金标准为-值。 -值表示研究人员是否可以认为观察到的差异显着,这意味着在原假设的假设下不太可能发生。在医学(和其他)研究中比较两组时,值的优势是压倒性的:Nuijten等。 []在荟萃分析中显示,1985年至2013年间期刊报道的258105个值中,有26%属于-统计量,另见Wetzels等。 []。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号